Lonza Walkersville, Inc.
Walkersville, MD
- UEI
- LEEXJC9L4NF5
- CAGE
- 0BCV0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- LNQ3EMLZGAW5
- RARMXSHNJ3Y8
- KE4GDRMUGZ21
- NCU5GFWTSLE7
- GWN2JBBJD574
-
- SAM.gov registration date
- Physical address
- 8830 Biggs Ford Rd, Walkersville, MD 21793, USA
- Website
- lonza.com
- Founded
- 1897
- Employees
- 10K-50K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$150,427 |
| FY2025 | $181,589 |
| FY2024 | $327,799 |
| FY2023 | $632,110 |
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Weems Design Studio, Inc. | 75N91023F00001 | $154,550 | |
| Research Triangle Institute | HHSN273201400022C | $34,780 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| D11AC00019 (legacy number: N10OT0003) - lonza walkersville, INC. ''engineered skin substitute (ESS) (permaderm) pre-IED… | Departmental Offices | $0 |
Similar vendors
About the company
Lonza Walkersville, Inc., a foreign-owned manufacturer of specialized biological materials and laboratory equipment headquartered in Walkersville, Maryland, supplies cryopreserved human cell preparations, cell culture media, transfection devices, and diagnostic reagents to federal biomedical research agencies as a prime contractor on full-and-open purchase orders and blanket purchase agreement calls.
The vendor holds a $10 million single-award Blanket Purchase Agreement with the HHS Office of Logistics and Acquisition Operations, valid through December 31, 2026, that enables streamlined procurement of biological materials, blood products, laboratory supplies, medical and scientific equipment, and repair and maintenance services across multiple NIH institutes. Lonza Walkersville operates through named subsidiaries including Lonza LLC, Lonza Rockland, Inc., Capsugel, Inc., Lonza Sales AG, and Arch Chemicals, Inc. Recent awards include a $30,645 NIEHS purchase order for sixty vials of spheroid-qualified cryopreserved primary human hepatocytes (thirty male and thirty female donors) to support microphysiological systems research at the National Center for Advancing Translational Sciences and NIEHS Mechanistic Toxicology Branch, with place of performance in Durham, North Carolina; a $24,329 FDA purchase order for a 4D Nucleofection System installed at FDA's Walkersville facility, awarded September 8, 2026; a $26,097 NIAID purchase order for a 4D-Nucleofector Core Unit, X Unit, and warranty extensions, awarded August 3, 2026; and a $86,358 FDA purchase order for human cells and cell culture reagents, awarded August 27, 2025.
Customer concentration is heavily weighted toward HHS intramural research. The top five customer agencies account for 31 percent of awards by count but 84 percent of combined potential value. The National Heart Lung and Blood Institute anchors the value ranking with 25 awards carrying $17.6 million combined potential value; the NIH Office of Logistics and Acquisition Operations holds 26 awards valued at $10.2 million; the NIH Clinical Center issued 40 awards for $1 million; and the FDA placed 38 awards totaling $889 thousand. By award count, the NIH Office of the Director leads with 169 awards, followed by the NIH Clinical Center with 40 awards, the FDA with 38 awards, and the National Cancer Institute with 38 awards. The vendor's work concentrates in pharmaceutical preparation manufacturing (190 awards), in-vitro diagnostic substance manufacturing (143 awards), and analytical laboratory instrument manufacturing (88 awards), with PSC coding dominated by laboratory equipment and supplies (463 awards) and drugs and biologicals (261 awards).
Activity has remained modest and variable—fifteen awards in 2022, eighteen in 2023, fourteen in 2024, five in 2025, and seven through September 2026—with a combined potential value across all 1,044 awards of $36.2 million and $11.7 million obligated. Only four awards carry ultimate completion dates within the next twenty-four months and combined potential value of $100 thousand. The vendor operates almost exclusively as a prime contractor; only two sub-awards appear in the record, issued to Weems Design Studio, Inc. for centralized chemopreventive agent repository and chemistry support work, and to Research Triangle Institute for National Toxicology Program chemistry services. Lonza Walkersville's largest parent vehicles are a Blanket Purchase Agreement (HHSN263199900049886B) with 180 task orders valued at $1 million combined potential value and a second BPA (HHSN263201600052B) with 46 task orders and $544 thousand combined potential value, both enabling efficient ordering of biomedical research consumables and equipment across federal research enterprises.
Quick answers
Is Lonza Walkersville, Inc. registered in SAM.gov?
Yes. Lonza Walkersville, Inc.'s SAM.gov registration is active through January 27, 2027.
Which contract vehicles does Lonza Walkersville, Inc. hold?
Lonza Walkersville, Inc. holds a place on 1 federal contract vehicle: Gene Insertion - Pluripotent Stem Cells 2012-2017.
How much has Lonza Walkersville, Inc. received in federal contracts?
Federal contracts obligated $181,589 to Lonza Walkersville, Inc. in fiscal year 2025 and $991,071 in fiscal years 2023 through 2027.
What is Lonza Walkersville, Inc.'s most recent federal award?
Lonza Walkersville, Inc.'s most recent federal contract award is Niehs: this acquisition will provide 60 vials of spheroid-qualified human liver cells from 30 male and 30 female donors… (75N98026P01800), from Office of Logisitics and Acquisition Operations (NIH), on September 29, 2026.
On GovTribe
See Lonza Walkersville, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors